The Medicines Company to Participate in the 27th Annual JP Morgan Healthcare Conference

• Press Release
• Source: The Medicines Company
• On 5:00 pm EST, Tuesday January 6, 2009

PARSIPPANY, NJ--(MARKET WIRE)--Jan 6, 2009 -- The Medicines Company (NasdaqGS:MDCO - News) is scheduled to participate in the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13th, at 9am Pacific Time, 12:00pm Eastern Time. A company overview and outlook will be provided in the presentation.

Related Quotes

Symbol	Price	Change
MDCO	7.88	+0.16

{"s" : "mdco","k" : "c10,l10,p20,t10","o" : "","j" : ""}

The session will be webcast with a link available at The Medicines Company's website: http://www.themedicinescompany.com.

MDCO-G

About The Medicines Company

The Medicines Company (NasdaqGS:MDCO - News) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax® (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex® (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Company also has an investigational antiplatelet agent, cangrelor, in late-stage development and a serine protease inhibitor, CU-2010, in early-stage development. The Company's website is www.themedicinescompany.com.

     Contact:
     Robyn Brown
     Vice President, Investor Relations
     The Medicines Company
     973-656-1616
     Email Contact